Nifty
Sensex
:
:
11937.65
40707.31
40.85 (0.34%)
162.94 (0.40%)

Pharmaceuticals & Drugs - API

Rating :
78/99  (View)

BSE: 524348 | NSE: AARTIDRUGS

769.10
-9.60 (-1.23%)
21-Oct-2020 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  793.70
  •  793.70
  •  761.00
  •  778.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  596390
  •  4586.84
  •  1026.95
  •  105.25

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 7,170.81
  • 35.08
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 7,542.51
  • 0.07%
  • 8.88

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 60.21%
  • 1.50%
  • 31.24%
  • FII
  • DII
  • Others
  • 2.19%
  • 1.85%
  • 3.01%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.68
  • 9.64
  • 13.24

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.40
  • 8.11
  • 5.63

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.66
  • 15.52
  • 19.77

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.36
  • 16.36
  • 15.50

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.39
  • 3.31
  • 3.24

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.04
  • 9.86
  • 9.90

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
545
405
34%
450
459
-2%
474
380
25%
478
347
37%
Expenses
411
351
17%
378
403
-6%
406
328
24%
409
300
36%
EBITDA
134
55
145%
71
56
28%
67
52
30%
68
47
45%
EBIDTM
25%
13%
16%
12%
14%
14%
14%
14%
Other Income
1
0
2000%
1
1
-20%
0
0
47%
0
0
90%
Interest
7
9
-30%
7
10
-28%
8
10
-20%
9
10
-12%
Depreciation
12
12
5%
12
11
16%
12
11
15%
12
11
14%
PBT
116
34
246%
61
40
53%
43
31
40%
48
27
79%
Tax
31
11
176%
2
12
-85%
15
10
54%
16
9
79%
PAT
85
22
281%
59
27
115%
28
21
33%
32
18
79%
PATM
16%
6%
13%
6%
6%
5%
7%
5%
EPS
36.67
9.64
280%
25.26
11.78
114%
11.92
8.96
33%
13.87
7.75
79%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 11
Mar 10
Mar 09
Mar 08
Net Sales
1,945
1,806
1,561
1,244
1,195
1,140
1,097
501
478
382
312
Net Sales Growth
22%
16%
26%
4%
5%
4%
119%
5%
25%
22%
 
Cost Of Goods Sold
1,229
1,127
1,014
738
744
735
724
321
301
239
197
Gross Profit
716
679
547
506
451
405
373
180
177
143
115
GP Margin
37%
38%
35%
41%
38%
36%
34%
36%
37%
37%
37%
Total Expenditure
1,604
1,541
1,350
1,042
1,005
960
925
432
396
316
267
Power & Fuel Cost
-
104
84
71
59
54
50
29
26
23
20
% Of Sales
-
6%
5%
6%
5%
5%
5%
6%
6%
6%
6%
Employee Cost
-
61
55
52
48
40
33
20
15
12
11
% Of Sales
-
3%
3%
4%
4%
4%
3%
4%
3%
3%
3%
Manufacturing Exp.
-
160
143
130
103
88
76
39
32
25
24
% Of Sales
-
9%
9%
10%
9%
8%
7%
8%
7%
7%
8%
General & Admin Exp.
-
21
14
12
13
11
10
5
5
4
3
% Of Sales
-
1%
1%
1%
1%
1%
1%
1%
1%
1%
1%
Selling & Distn. Exp.
-
59
38
34
31
28
29
16
14
12
10
% Of Sales
-
3%
2%
3%
3%
2%
3%
3%
3%
3%
3%
Miscellaneous Exp.
-
7
3
4
6
4
2
1
2
1
10
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
1%
EBITDA
341
266
211
202
190
180
172
69
82
66
46
EBITDA Margin
18%
15%
14%
16%
16%
16%
16%
14%
17%
17%
15%
Other Income
3
1
6
1
4
0
1
0
1
1
2
Interest
31
37
44
38
40
48
42
17
19
26
14
Depreciation
49
49
43
40
38
37
31
19
17
14
13
PBT
268
181
131
124
116
95
100
33
47
26
20
Tax
64
44
41
42
34
27
22
10
19
8
5
Tax Rate
24%
24%
32%
34%
29%
28%
23%
29%
40%
33%
26%
PAT
204
141
90
82
82
69
77
24
28
17
14
PAT before Minority Interest
204
141
90
82
82
69
77
24
28
18
15
Minority Interest
0
0
0
0
0
0
0
0
0
-1
-1
PAT Margin
11%
8%
6%
7%
7%
6%
7%
5%
6%
4%
5%
PAT Growth
130%
58%
9%
1%
19%
-11%
229%
-16%
68%
19%
 
EPS
87.73
60.69
38.52
35.33
35.11
29.49
33.15
10.09
12.04
7.17
6.04

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 11
Mar 10
Mar 09
Mar 08
Shareholder's Funds
652
543
455
400
357
308
163
146
123
112
Share Capital
23
24
24
24
24
24
12
12
12
12
Total Reserves
629
520
432
376
333
284
151
134
112
100
Non-Current Liabilities
299
328
312
297
244
211
290
210
211
233
Secured Loans
172
200
191
187
177
153
205
139
161
128
Unsecured Loans
9
9
12
14
15
11
63
50
31
90
Long Term Provisions
24
20
17
8
1
0
0
0
0
0
Current Liabilities
625
591
622
494
501
483
70
58
60
57
Trade Payables
330
243
259
197
185
167
65
50
55
54
Other Current Liabilities
133
83
56
51
44
42
2
2
1
1
Short Term Borrowings
158
263
306
245
258
252
0
0
0
0
Short Term Provisions
5
2
1
2
14
22
3
6
4
2
Total Liabilities
1,576
1,463
1,389
1,191
1,102
1,002
523
419
403
417
Net Block
644
625
602
581
493
448
248
208
205
190
Gross Block
1,031
972
909
848
725
685
393
332
310
278
Accumulated Depreciation
387
347
307
267
232
237
145
124
105
88
Non Current Assets
672
679
653
620
537
476
264
213
207
218
Capital Work in Progress
12
33
28
14
34
16
10
3
1
15
Non Current Investment
13
12
11
12
5
5
5
2
2
13
Long Term Loans & Adv.
3
9
11
12
5
7
0
0
0
0
Other Non Current Assets
0
0
0
0
0
0
0
0
0
0
Current Assets
904
784
737
571
565
526
260
206
196
199
Current Investments
0
0
0
0
0
0
0
0
0
0
Inventories
325
247
278
210
178
164
92
64
61
66
Sundry Debtors
489
459
375
297
332
314
121
116
113
103
Cash & Bank
8
6
4
4
5
4
5
9
3
4
Other Current Assets
82
7
10
0
50
43
42
17
18
25
Short Term Loans & Adv.
76
67
69
61
50
43
41
16
18
24
Net Current Assets
279
193
115
77
64
43
190
148
136
141
Total Assets
1,576
1,463
1,389
1,191
1,102
1,002
523
419
403
417

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 11
Mar 10
Mar 09
Mar 08
Cash From Operating Activity
251
143
70
175
133
105
21
59
65
28
PBT
185
131
124
116
95
100
33
47
26
20
Adjustment
87
75
75
72
79
69
39
39
42
28
Changes in Working Capital
19
-33
-105
8
-21
-50
-40
-13
2
-15
Cash after chg. in Working capital
292
173
94
196
153
120
32
73
70
32
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-41
-30
-25
-21
-20
-15
-11
-14
-5
-4
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
-33
-62
-74
-107
-99
-107
-76
-30
-12
-33
Net Fixed Assets
-47
-64
-73
-93
-46
-322
-65
-23
-20
-22
Net Investments
-1
-2
1
-7
0
14
-3
0
12
-12
Others
16
4
-2
-7
-52
202
-8
-7
-4
1
Cash from Financing Activity
-215
-80
4
-68
-33
1
53
-24
-54
4
Net Cash Inflow / Outflow
2
1
0
0
1
-1
-3
5
-1
-1
Opening Cash & Equivalents
5
3
3
4
4
5
9
3
4
5
Closing Cash & Equivalent
7
5
3
3
5
4
5
9
3
4

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 11
Mar 10
Mar 09
Mar 08
Book Value (Rs.)
70
230
193
168
148
127
67
60
53
48
ROA
9%
6%
6%
7%
7%
10%
5%
7%
4%
4%
ROE
24%
18%
19%
22%
21%
33%
15%
21%
15%
14%
ROCE
21%
17%
17%
18%
18%
24%
13%
20%
16%
11%
Fixed Asset Turnover
1.81
1.66
1.44
1.64
1.75
2.19
1.45
1.57
1.42
1.26
Receivable days
96
97
97
89
96
67
82
83
95
99
Inventory Days
58
61
71
55
51
40
54
45
56
70
Payable days
65
68
74
68
66
46
46
47
63
60
Cash Conversion Cycle
89
91
94
76
81
61
90
81
88
109
Total Debt/Equity
0.58
0.93
1.20
1.20
1.26
1.45
1.64
1.29
1.56
1.95
Interest Cover
6
4
4
4
3
3
3
4
2
2

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.